Ketamine for chronic pain is an FDA-approved anesthetic now used off-label at low, controlled doses for treatment-resistant nerve pain and depression. The evidence is promising but nuanced — here is what is real and what is hype, explained by a pain specialist.
Ketamine has gone from operating-room anesthetic to one of the most talked-about treatments in both pain management and mental health. Clinics are opening across the country, and the claims can sound almost too good to be true. So what is actually real? As with most things in medicine, the honest answer is: it depends on what you are treating.
What ketamine actually is
Ketamine is a decades-old anesthetic that works differently from opioids and most other pain or psychiatric medications. Rather than acting on opioid receptors, it blocks a receptor in the nervous system called the NMDA receptor and influences glutamate, one of the brain’s main signaling chemicals. At low (“subanesthetic”) doses, it can change how the brain and spinal cord process pain and mood — which is why researchers began studying it for conditions that do not respond to standard treatment.
Ketamine for depression: where the evidence is strongest
This is where ketamine has earned the most legitimate ground. A form of ketamine called esketamine (brand name Spravato) is FDA-approved for treatment-resistant depression — depression that has not improved after at least two standard antidepressants. In January 2025, the FDA went further and approved Spravato as a standalone (monotherapy) treatment, meaning it can be used without another antidepressant alongside it.
What makes it notable is speed: standard antidepressants can take weeks, while ketamine often improves symptoms within hours to a day. In clinical trials, a meaningful share of patients reached remission within a few weeks. Intravenous (IV) racemic ketamine is also used off-label for depression with similar rapid effects, though it is not FDA-approved for that specific purpose. The caveats are real: the effects can fade, so treatment usually involves a series of supervised sessions delivered in a monitored medical setting — not a take-home prescription.
Ketamine for chronic pain: a more mixed picture
Here is where honesty matters most, because the marketing often outpaces the evidence. In 2018, three major medical societies (ASRA, AAPM, and ASA) published the first consensus guidelines on IV ketamine infusions for chronic pain. Their conclusions were carefully measured:
- Complex regional pain syndrome (CRPS): there is moderate evidence that ketamine infusions can reduce pain for up to about 12 weeks in this severe, hard-to-treat nerve condition.
- Most other chronic pain conditions — including fibromyalgia, phantom limb pain, postherpetic neuralgia, cancer pain, and low back pain — have weak or no evidence for meaningful pain relief, especially over the long term.
- Spinal cord injury pain: there is weak evidence for short-term relief.
In plain terms: ketamine is a genuine option worth considering for certain treatment-resistant pain conditions, but it is not a proven cure-all for chronic pain — and anyone promising guaranteed results is overselling it.
What treatment is actually like
Medical ketamine for pain or mood is given as a carefully dosed IV infusion or, for esketamine, a nasal spray — always under supervision. Sessions are monitored because ketamine can cause temporary dissociation (a floating, detached feeling), increases in blood pressure and heart rate, nausea, and grogginess. These usually resolve after the session. Long-term or unsupervised misuse carries more serious risks, including bladder and urinary problems, which is exactly why this is not a do-it-yourself therapy.
The bottom line: real, but not magic
Ketamine is a real, evidence-supported tool — clearly so for treatment-resistant depression, and reasonably so for specific pain conditions like CRPS. It is not a miracle cure for all chronic pain, and the gap between the marketing and the science is where patients can get hurt, both financially and medically. The smartest approach is a proper evaluation with a physician who will tell you honestly whether you are likely to benefit.
Considering ketamine therapy? UPC Regenerative Medicine, directed by Dr. Guiang, offers supervised ketamine treatment for conditions including depression, PTSD, anxiety, and fibromyalgia, alongside a range of other regenerative therapies. You can book a 20-minute telemedicine consult to discuss whether you are a candidate at UPC Regenerative Medicine.
This article is for general education and is not medical advice. Ketamine therapy is a prescription medical treatment that must be evaluated and supervised by a qualified clinician. Always discuss your specific situation with your own physician.
Frequently asked questions about ketamine for chronic pain
Is ketamine for chronic pain FDA-approved?
Ketamine itself is FDA-approved as an anesthetic. Its use for chronic pain and depression is largely off-label, while the related drug esketamine (Spravato) is FDA-approved for treatment-resistant depression.
How is ketamine given for chronic pain?
It is most often delivered as a supervised low-dose IV infusion in a clinical setting, with monitoring of blood pressure, heart rate, and side effects.
Is ketamine a cure for chronic pain?
No. Ketamine for chronic pain may provide relief for some people with nerve-related pain, but it is one tool within a comprehensive plan, not a stand-alone cure.
Related articles
Sources & further reading
Medically reviewed by Rainier Guiang, MD — last reviewed June 2026. This article is educational and is not a substitute for individual medical advice.